동충하초 (시넨시스)
Cordyceps sinensis
📚 관련 논문 (19편)
1. J Evid Based Med. 2025 Dec;18(4):e70091. doi: 10.1111/jebm.70091. Epub 2025 Nov 26. The Effectiveness of Yong Chong Cao Capsule in Patients With Mild to Severe COPD: A Multi-Center, Randomized, Active-Controlled Trial. Li S(1)(2)(3), Xie Y(1)(2)(3), Lin L(4), Wu L(5), Yu X(6), Ma Z(7), Yin Q(
2. Food Funct. 2024 Apr 22;15(8):4010-4020. doi: 10.1039/d3fo03770c. Cordyceps sinensis accelerates stem cell recruitment to human skeletal muscle after exercise. Dewi L(1)(2), Liao YC(1), Jean WH(3), Huang KC(4), Huang CY(5)(6)(7)(8), Chen LK(9)(10)(11), Nicholls A(1), Lai LF(1), Kuo CH(1)(12)(
3. Nat Prod Res. 2025 Sep;39(18):5313-5317. doi: 10.1080/14786419.2024.2369235. Epub 2024 Jun 17. The synergistic effect of Cordyceps sinensis and Gymnema inodorum (Lour.) Decne. extracts on amelioration of glucose intolerance and dyslipidemia in high-fat diet-fed mice. Sirichaiwetchakoon K(1),
4. PLoS One. 2014 Mar 12;9(3):e91830. doi: 10.1371/journal.pone.0091830. eCollection 2014. Oral Chinese herbal medicine combined with pharmacotherapy for stable COPD: a systematic review of effect on BODE index and six minute walk test. Chen X(1), May B(2), Di YM(2), Zhang AL(2), Lu C(3), Xue CC
5. Mol Cell Endocrinol. 2014 Feb 15;382(2):979-88. doi: 10.1016/j.mce.2013.11.018. Epub 2013 Dec 2. Cordyceps sinensis polysaccharide CPS-2 protects human mesangial cells from PDGF-BB-induced proliferation through the PDGF/ERK and TGF-β1/Smad pathways. Wang Y(1), Liu D(2), Zhao H(2), Jiang H(3),
6. Integr Cancer Ther. 2011 Dec;10(4):359-67. doi: 10.1177/1534735410392573. Epub 2011 Mar 7. Polysaccharide of Cordyceps sinensis enhances cisplatin cytotoxicity in non-small cell lung cancer H157 cell line. Ji NF(1), Yao LS, Li Y, He W, Yi KS, Huang M. Author information: (1)Jiangsu Provincia
7. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2009 Mar;38(2):158-62. doi: 10.3785/j.issn.1008-9292.2009.02.007. [Cordyceps sinensis polysaccharide enhances apoptosis of HL-60 cells induced by triptolide]. [Article in Chinese] Shen YD(1), Shao XT, Ni YD, Xu H, Tong XM. Author information: (1)The Clini
8. Front Biosci (Landmark Ed). 2009 Jan 1;14(10):3864-71. doi: 10.2741/3494. The synergistic effects of C. Sinensis with CsA in preventing allograft rejection. Ding C(1), Tian P, Jia L, Li Y, Ding X, Xiang H, Xue W, Zhao Y. Author information: (1)Department of Renal Transplantation, Nephropathy
9. Transpl Immunol. 2008 Jul;19(3-4):159-66. doi: 10.1016/j.trim.2008.05.010. Epub 2008 Jul 9. C. sinensis ablates allograft vasculopathy when used as an adjuvant therapy with cyclosporin A. Jordan JL(1), Hirsch GM, Lee TD. Author information: (1)Department of Pathology, Dalhousie University, 5
10. Zhong Xi Yi Jie He Xue Bao. 2006 Mar;4(2):185-8. doi: 10.3736/jcim20060215. [Effects of compound preparation of Cordyceps sinensis and Tripterygium hypoglaucum on survival time of pigskin after allogeneic transplantation]. [Article in Chinese] Cheng DW(1), Zou Y, Qian N, Wang CL, Tian YB, Wa
11. Phytomedicine. 2005 Apr;12(4):255-63. doi: 10.1016/j.phymed.2004.01.008. Formulation and in vitro/in vivo evaluation of combining DNA repair and immune enhancing nutritional supplements. Pero RW(1), Amiri A, Sheng Y, Welther M, Rich M. Author information: (1)Department of Cell and Molecular
12. World J Gastroenterol. 2003 Mar;9(3):529-33. doi: 10.3748/wjg.v9.i3.529. Inhibitive effect of cordyceps sinensis on experimental hepatic fibrosis and its possible mechanism. Liu YK(1), Shen W. Author information: (1)Department of Gastroenterology, the Second affiliated hospital, Chongqing U
13. Appl Microbiol Biotechnol. 2020 Jun;104(11):4675-4703. doi: 10.1007/s00253-020-10476-4. Epub 2020 Apr 9. Mushroom extracts and compounds with suppressive action on breast cancer: evidence from studies using cultured cancer cells, tumor-bearing animals, and clinical trials. Wong JH(1), Ng TB
14. Int J Biol Macromol. 2024 Dec;282(Pt 5):137275. doi: 10.1016/j.ijbiomac.2024.137275. Epub 2024 Nov 5. A systematic review on polysaccharides from fermented Cordyceps sinensis: Advances in the preparation, structural characterization, bioactivities, structure-activity relationships. Yao L(1)
15. J Ethnopharmacol. 2024 Jun 12;327:118044. doi: 10.1016/j.jep.2024.118044. Epub 2024 Mar 12. Adjuvant treatment with Cordyceps sinensis for lung cancer: A systematic review and meta-analysis of randomized controlled trials. Wang C(1), Wang J(1), Qi Y(2). Author information: (1)Shandong Unive
33. J Tradit Chin Med. 2019 Feb;39(1):1-14. Efficacy of Cordyceps sinensis as an adjunctive treatment in hemodialysis patients: a systematic review and Meta-analysis. Bee Yean O(1), Zoriah A(2). Author information: (1)Zoriah Aziz, Department of Pharmacy, Faculty of Medicine, University of Malay
21. Complement Ther Med. 2017 Feb;30:84-92. doi: 10.1016/j.ctim.2016.12.007. Epub 2016 Dec 21. Efficacy of Cordyceps sinensis as an adjunctive treatment in kidney transplant patients: A systematic-review and meta-analysis. Ong BY(1), Aziz Z(2). Author information: (1)Department of Pharmacy, Fac
43. Cochrane Database Syst Rev. 2015 Oct 12;2015(10):CD009698. doi: 10.1002/14651858.CD009698.pub2. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients. Hong T(1), Zhang M, Fan J. Author information: (1)Department of Nephrology, Sixth People's Hospital of Chengd
22. Cochrane Database Syst Rev. 2014 Dec 18;2014(12):CD008353. doi: 10.1002/14651858.CD008353.pub2. Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease. Zhang HW(1), Lin ZX, Tung YS, Kwan TH, Mok CK, Leung C, Chan LS. Author information: (1)School of Chinese
⚠️ 면책 고지
이 정보는 일반 교육 목적이며 의료 진단/처방을 대체하지 않습니다.